These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36882216)

  • 1. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E; Lorentz A
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
    PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
    Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
    J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 11. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
    World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Lv L; Wang C
    Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
    Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Wang Y; Hu Y; Shi P
    BMC Gastroenterol; 2024 Jul; 24(1):217. PubMed ID: 38970007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Singh P; Alm EJ; Kelley JM; Cheng V; Smith M; Kassam Z; Nee J; Iturrino J; Lembo A
    Gut Microbes; 2022; 14(1):2020067. PubMed ID: 35014601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
    Myneedu K; Deoker A; Schmulson MJ; Bashashati M
    United European Gastroenterol J; 2019 Oct; 7(8):1033-1041. PubMed ID: 31662860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
    Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.